Pain News and Research

Latest Pain News and Research

Biogen, Sobi present new data supporting clinical, safety profile of ELOCTATE for hemophilia A

Biogen Idec nd Swedish Orphan Biovitrum AB (publ) presented new data that support the clinical and safety profile of their long-lasting recombinant factor VIII candidate ELOCTATE for hemophilia A.

4 Jul 2013

Updated EULAR recommendations for management of rheumatoid arthritis

The European League Against Rheumatism has released updated recommendations for the management of RA. According to this latest guidance, treatment with disease-modifying anti-rheumatic drugs should be initiated as soon as a diagnosis of RA is made, with the aim of reaching a target of remission or low disease activity in every patient.

4 Jul 2013

Texas abortion bill sent to full chamber

A Texas House committee approved sweeping abortion legislation early Wednesday, setting up a new fight on the proposal that would, along with other restrictions, ban abortions after 20 weeks of pregnancy. The full chamber will take up the proposal early next week.

4 Jul 2013

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

Orexo today announced that it has received approval from the U.S. Food and Drug Administration for Zubsolv (buprenorphine/naloxone) sublingual tablet CIII.

4 Jul 2013

First Edition: July 3, 2013

Today's headlines detail the Obama administration announcement that it would delay the health law rule requiring businesses provide insurance to workers.

3 Jul 2013

Arthritis Research UK awards grant to develop new treatments for severe arthritis pain

Medical research charity Arthritis Research UK has awarded researchers at University College London and the University of Nottingham a grant of £800,000 to develop new treatments for severe arthritis pain.

3 Jul 2013

Wake Forest Baptist to extend innovation in geriatrics education with new GPS program

Wake Forest Baptist Medical Center will maintain its position as a leader in geriatric medicine and medical training with continued grant funding from the Donald W. Reynolds Foundation.

3 Jul 2013

Weekly yoga class provides similar lower back pain relief as twice weekly classes for low-income patients

Researchers at Boston University School of Medicine and Boston Medical Center have found that a weekly yoga class provided similar lower back pain relief and reduced the need for pain medication as twice weekly classes in lower income minority patients.

3 Jul 2013

Home-based exercise intervention improves walking performance, physical activity in PAD patients

In a trial that included nearly 200 participants with peripheral artery disease, a home-based exercise intervention with a group-mediated cognitive behavioral intervention component improved walking performance and physical activity in patients with PAD, according to a study in the July 3 issue of JAMA.

3 Jul 2013

CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

Cell Therapeutics, Inc. today announced that a comprehensive article summarizing preclinical and clinical data for pacritinib, an oral JAK2/FLT3 inhibitor, authored by Srdan Verstovsek, M.D., Ph.D., et al., was published in the journal Drugs of the Future 2013.

3 Jul 2013

Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

Biogen Idec and Swedish Orphan Biovitrum AB (publ) today presented new findings for their long-lasting recombinant factor IX candidate ALPROLIX for hemophilia B at the XXIV International Society on Thrombosis and Haemostasis Congress in Amsterdam, The Netherlands.

3 Jul 2013

Researchers report that aerobic exercise can lessen or worsen ulcerative colitis symptoms

Aerobic exercise can lessen - or worsen - the symptoms of inflammatory bowel diseases such as ulcerative colitis, depending on the circumstances under which the exercise is undertaken, researchers report.

3 Jul 2013

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms or so far none at all, and in whom chemotherapy is not yet indicated.

3 Jul 2013

Study shows humorous creativity increases when individuals are primed with thoughts of death

Humor is an intrinsic part of human experience. It plays a role in every aspect of human existence, from day-to-day conversation to television shows. Yet little research has been conducted to date on the psychological function of humor.

3 Jul 2013

Salsalate lowers blood glucose and improves glycemic control in T2D, say scientists

Joslin scientists report that salsalate, a drug used to treat arthritis, lowers blood glucose and improves glycemic control in type 2 diabetes. These findings, which were published today by the Annals of Internal Medicine, provide additional evidence that salsalate may be an effective drug to treat type 2 diabetes.

3 Jul 2013

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

ARIAD Pharmaceuticals, Inc. today announced that the European Commission has granted a marketing authorization for Iclusig (ponatinib) as an orphan medicinal product for two indications.

2 Jul 2013

State highlights: Calif. bill to fine firms with workers on Medi-Cal fails; Pa. eyes disallowing apologies used against doctors in court-proceedings

A California proposal to fine large companies that have workers on Medi-Cal came up short in an initial vote in the Assembly amid strong business opposition. The proposed fines could reach about $5,000 per full-time employee who receives Medi-Cal, the state Medicaid program for the poor. The bill, AB 880, garnered 46 votes in the 80-member chamber Thursday, short of the 54 votes, or two-thirds majority, needed. The measure could come up for reconsideration as early as next week (Terhune, 6/27).

2 Jul 2013

Research roundup: 'Welcome-mat' effect of Medicaid expansion; Setting up shops; California's transition to Medicaid managed care

The number of people eligible for Medicaid who remain uninsured varies from state to state, according to the authors. But the federal health law is likely to increase the rate of enrollment for this group. The potential impact of this increase in Medicaid enrollment, also known as the 'welcome-mat' effect, is unclear.

2 Jul 2013

Osteoarthritis associated genes: an interview with Professor Jonathan Tobias, University of Bristol

Joints are lined by articular cartilage, loss of which is one of the hallmarks of osteoarthritis. Articular cartilage is made up of a number of proteins, such as type II collagen. In rare forms of osteoarthritis, one of these structural proteins is defective as a result of a genetic mutation.

2 Jul 2013

Lawmakers gird for new abortion fight as Texas special session convenes

Texas lawmakers resume debate on proposed abortion legislation as the state legislature opens a special session Monday. Republicans say they will quickly pass new abortion restrictions despite opponents' efforts. Meanwhile, the Congressional Budget Office projected that a House bill that would ban abortions after 20 weeks would increase Medicaid costs by as much as $400 million.

2 Jul 2013

Pain News and Research

Latest Pain News and Research

Biogen, Sobi present new data supporting clinical, safety profile of ELOCTATE for hemophilia A

Updated EULAR recommendations for management of rheumatoid arthritis

Texas abortion bill sent to full chamber

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

First Edition: July 3, 2013

Arthritis Research UK awards grant to develop new treatments for severe arthritis pain

Wake Forest Baptist to extend innovation in geriatrics education with new GPS program

Weekly yoga class provides similar lower back pain relief as twice weekly classes for low-income patients

Home-based exercise intervention improves walking performance, physical activity in PAD patients

CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

Researchers report that aerobic exercise can lessen or worsen ulcerative colitis symptoms

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Study shows humorous creativity increases when individuals are primed with thoughts of death

Salsalate lowers blood glucose and improves glycemic control in T2D, say scientists

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

State highlights: Calif. bill to fine firms with workers on Medi-Cal fails; Pa. eyes disallowing apologies used against doctors in court-proceedings

Research roundup: 'Welcome-mat' effect of Medicaid expansion; Setting up shops; California's transition to Medicaid managed care

Osteoarthritis associated genes: an interview with Professor Jonathan Tobias, University of Bristol

Lawmakers gird for new abortion fight as Texas special session convenes

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in